PL206458B1 - Zastosowanie siarczanowanych glikozoaminoglikanów w położnictwie - Google Patents

Zastosowanie siarczanowanych glikozoaminoglikanów w położnictwie

Info

Publication number
PL206458B1
PL206458B1 PL370428A PL37042803A PL206458B1 PL 206458 B1 PL206458 B1 PL 206458B1 PL 370428 A PL370428 A PL 370428A PL 37042803 A PL37042803 A PL 37042803A PL 206458 B1 PL206458 B1 PL 206458B1
Authority
PL
Poland
Prior art keywords
labor
molecular weight
cervix
heparins
glycosaminoglycans
Prior art date
Application number
PL370428A
Other languages
English (en)
Polish (pl)
Other versions
PL370428A1 (en
Inventor
Gunvor Ekman-Ordeberg
Anders Malmström
Original Assignee
Dilafor Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dilafor Ab filed Critical Dilafor Ab
Publication of PL370428A1 publication Critical patent/PL370428A1/xx
Publication of PL206458B1 publication Critical patent/PL206458B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL370428A 2002-01-02 2003-01-02 Zastosowanie siarczanowanych glikozoaminoglikanów w położnictwie PL206458B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0200005A SE521676C2 (sv) 2002-01-02 2002-01-02 Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet

Publications (2)

Publication Number Publication Date
PL370428A1 PL370428A1 (en) 2005-05-30
PL206458B1 true PL206458B1 (pl) 2010-08-31

Family

ID=20286575

Family Applications (1)

Application Number Title Priority Date Filing Date
PL370428A PL206458B1 (pl) 2002-01-02 2003-01-02 Zastosowanie siarczanowanych glikozoaminoglikanów w położnictwie

Country Status (21)

Country Link
US (3) US7407945B2 ( )
EP (1) EP1461049B1 ( )
JP (1) JP4434741B2 ( )
KR (1) KR100958691B1 ( )
CN (1) CN100341518C ( )
AT (1) ATE395067T1 ( )
AU (1) AU2003201787B2 ( )
CA (1) CA2472093C ( )
CY (1) CY1108260T1 ( )
DE (1) DE60320931D1 ( )
DK (1) DK1461049T3 ( )
ES (1) ES2306852T3 ( )
IL (2) IL162664A0 ( )
NO (1) NO332702B1 ( )
NZ (1) NZ533856A ( )
PL (1) PL206458B1 ( )
PT (1) PT1461049E ( )
SE (1) SE521676C2 ( )
SI (1) SI1461049T1 ( )
WO (1) WO2003055499A1 ( )
ZA (1) ZA200405015B ( )

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE521676C2 (sv) 2002-01-02 2003-11-25 Dilafor Ab Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet
WO2005007223A2 (en) * 2003-07-16 2005-01-27 Sasha John Programmable medical drug delivery systems and methods for delivery of multiple fluids and concentrations
CN104144950B (zh) 2011-12-19 2017-09-05 迪乐方有限责任公司 含有重复的二糖单元的非抗凝的葡糖胺聚糖及其医药用途
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
HK1203370A1 (en) * 2012-03-26 2015-10-30 迪乐方有限责任公司 Method for treatment of labor arrest
HK1203369A1 (en) * 2012-03-26 2015-10-30 迪乐方有限责任公司 Combination treatment comprising sulphated glycosaminoglycans for inducing labor
JP2015516415A (ja) * 2012-05-08 2015-06-11 ディラフォール・アクチボラゲットＤｉｌａｆｏｒ Ａｂ 化学修飾ヘパリンまたはヘパラン硫酸および子宮収縮剤を用いた分娩後出血の処置
TW201425332A (zh) 2012-08-03 2014-07-01 Revo Biolog Inc 抗凝血酶用於體外膜氧合之用途
JP7621366B2 (ja) 2020-02-17 2025-01-24 ディラフォール アクチエボラグ 子癇前症の処置のためのタフォキシパリン
EP4272749A1 (en) 2022-05-03 2023-11-08 Dilafor AB New medical use of tafoxiparin
AU2023266079A1 (en) 2022-05-03 2024-10-31 Dilafor Ab New medical use of tafoxiparin

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223263A (en) * 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
EP0209924A1 (en) * 1985-07-12 1987-01-28 Akzo N.V. New anti-trombosis agent based on glycosaminoglycan, process for its preparation, and pharmaceutical compositions
US4916122A (en) * 1987-01-28 1990-04-10 University Of Georgia Research Foundation, Inc. 3'-Azido-2',3'-dideoxyuridine anti-retroviral composition
US5190926A (en) * 1987-01-28 1993-03-02 University Of Georgia Research Foundation, Inc. 3'-azido-2',3'-dideoxypyrimidines and related compounds as antiviral agents
SE8702254D0 (sv) 1987-05-29 1987-05-29 Kabivitrum Ab Novel heparin derivatives
GB8719367D0 (en) * 1987-08-15 1987-09-23 Wellcome Found Therapeutic compounds
US5736531A (en) * 1987-10-28 1998-04-07 Pro-Neuron, Inc. Compositions of chemotherapeutic agent or antiviral agent with acylated pyrimidine nucleosides
US6020322A (en) * 1993-11-09 2000-02-01 Pro-Neuron, Inc. Acyl deoxyribonucleoside derivatives and uses thereof
US5968914A (en) * 1987-10-28 1999-10-19 Pro-Neuron, Inc. Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
US5470838A (en) * 1987-10-28 1995-11-28 Pro-Neuron, Inc. Method of delivering exogenous uridine or cytidine using acylated uridine or cytidine
US5411947A (en) * 1989-06-28 1995-05-02 Vestar, Inc. Method of converting a drug to an orally available form by covalently bonding a lipid to the drug
US5194654A (en) * 1989-11-22 1993-03-16 Vical, Inc. Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
US5149794A (en) * 1990-11-01 1992-09-22 State Of Oregon Covalent lipid-drug conjugates for drug targeting
US5543389A (en) * 1990-11-01 1996-08-06 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non Profit Organization Covalent polar lipid-peptide conjugates for use in salves
US5543390A (en) * 1990-11-01 1996-08-06 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Covalent microparticle-drug conjugates for biological targeting
US5256641A (en) * 1990-11-01 1993-10-26 State Of Oregon Covalent polar lipid-peptide conjugates for immunological targeting
US5280016A (en) 1991-03-29 1994-01-18 Glycomed Incorporated Non-anticoagulant heparin derivatives
US5554728A (en) * 1991-07-23 1996-09-10 Nexstar Pharmaceuticals, Inc. Lipid conjugates of therapeutic peptides and protease inhibitors
SE9302135D0 (sv) * 1993-06-18 1993-06-18 Kabi Pharmacia Ab New pharmaceutical composition
US5587362A (en) * 1994-01-28 1996-12-24 Univ. Of Ga Research Foundation L-nucleosides
US5559101A (en) * 1994-10-24 1996-09-24 Genencor International, Inc. L-ribofuranosyl nucleosides
EP0831852B1 (en) * 1995-06-07 2006-11-29 Emory University Nucleosides with anti-hepatitis b virus activity
US6025335A (en) * 1995-09-21 2000-02-15 Lipitek International, Inc. L-Nucleoside Dimer Compounds and therapeutic uses
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
AU4572797A (en) * 1996-10-15 1998-05-11 Toray Industries, Inc. Cervical canal maturing agent
JP4412756B2 (ja) 1998-02-26 2010-02-10 生化学工業株式会社 新規多糖誘導体、その製造法及びそれを有効成分とする医薬組成物
MXPA00012842A (es) * 1998-06-24 2004-06-22 Univ Emory Uso de 3'-azido-2',3'-didesoxiuridina en combinacion de drogas adicionales contra el vih para la manufactura de un medicamento para el tratamiento del vih.
IL127896A0 (en) * 1998-12-31 1999-10-28 Gail Laster A novel treatment for preeclampsia and related diseases
JP2000309544A (ja) * 1999-02-25 2000-11-07 Seikagaku Kogyo Co Ltd 早産または流産防止剤および子宮頚管熟化抑制剤ならびにヒアルロニダーゼの阻害剤
SE521676C2 (sv) 2002-01-02 2003-11-25 Dilafor Ab Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet

Also Published As

Publication number Publication date
ES2306852T3 (es) 2008-11-16
AU2003201787B2 (en) 2008-02-28
CN100341518C (zh) 2007-10-10
SE521676C2 (sv) 2003-11-25
CA2472093A1 (en) 2003-07-10
SI1461049T1 (sl) 2008-12-31
JP2005513148A (ja) 2005-05-12
IL162664A (en) 2009-06-15
KR20040075917A (ko) 2004-08-30
NZ533856A (en) 2004-12-24
NO20043190L (no) 2004-07-26
ZA200405015B (en) 2005-08-31
IL162664A0 (en) 2005-11-20
AU2003201787A1 (en) 2003-07-15
SE0200005D0 (sv) 2002-01-02
DE60320931D1 (de) 2008-06-26
CA2472093C (en) 2011-02-22
SE0200005L (sv) 2003-07-03
PT1461049E (pt) 2008-08-22
US20120225843A1 (en) 2012-09-06
DK1461049T3 (da) 2008-09-15
CY1108260T1 (el) 2014-02-12
EP1461049B1 (en) 2008-05-14
US8524688B2 (en) 2013-09-03
CN1612741A (zh) 2005-05-04
HK1076389A1 (en) 2006-01-20
WO2003055499A1 (en) 2003-07-10
US8207145B2 (en) 2012-06-26
EP1461049A1 (en) 2004-09-29
ATE395067T1 (de) 2008-05-15
US7407945B2 (en) 2008-08-05
PL370428A1 (en) 2005-05-30
JP4434741B2 (ja) 2010-03-17
NO332702B1 (no) 2012-12-10
US20080269165A1 (en) 2008-10-30
US20050075314A1 (en) 2005-04-07
KR100958691B1 (ko) 2010-05-18

Similar Documents

Publication Publication Date Title
US8524688B2 (en) Use of sulfated glycosaminoglycans for establishing effective labor in women
CN104244957B (zh) 用于治疗分娩停止的方法
CN104203256B (zh) 用于引产的包含硫酸化的葡糖胺聚糖的联合治疗
US20150099703A1 (en) Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agent
HK1076389B (en) Use of sulfated glycosaminoglycans for the manufacture of a pharmaceutical preparation for the prevention and treatment of slow progress of term labor

Legal Events

Date Code Title Description
RECP Rectifications of patent specification